Anti-Müllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis
American Journal of Obstetrics and Gynecology · 2025
DOI: 10.1016/j.ajog.2025.01.044 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Obstetrics and Gynecology, 2025. Verfasst von Mariane de Oliveira Gomes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro - UFTM, Abadia, Uberaba-MG, Brazil. Electronic address: mariane…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Anti-Mullerian Hormone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
OBJECTIVE: To determine whether serum anti-Müllerian hormone measurement can be used as a diagnostic marker for polycystic ovary syndrome compared to serum androgen measurement and transvaginal/transabdominal ultrasound. DATA SOURCES: A systematic literature review and meta-analysis were conducted. Electronic and manual searches were carried out in the Cochrane Library, Embase, Latin American and Caribbean Health Sciences Literature (LILACS), PubMed, Scopus, Web of Science, and Google Scholar databases. STUDY ELIGIBILITY CRITERIA: Studies conducted in humans, published in any language up to August 2023, and addressing the following research question were included: "Can serum anti-Müllerian hormone levels be used as a diagnostic marker of polycystic ovary syndrome in comparison to serum androgen levels and transvaginal/transabdominal ultrasound?" Furthermore, only articles that used the Rotterdam (2003) criteria, the National Institutes of Health (1990) criteria, the Androgen Excess and Polycystic Ovary Syndrome Society criteria, or the Evidence-based Guidelines on polycystic ovary syndrome from 2013, 2018, and 2023 for diagnosing women with polycystic ovary syndrome were included. STUDY APPRAISAL AND SYNTHESIS METHODS: Two independent reviewers selected the studies and extracted and analyzed the data. The Quality Assessment of Diagnostic Accuracy Studies-2 and Grades of Recommendation, Assessment, Development, and Evaluation Working Group tools were used to analyze the risk of bias and certainty of evidence. RESULTS: This systematic review included 45 studies. The studies exhibited a low risk of bias in the "Reference standard" and "Flow and time" domains but showed a moderate risk of bias in the "Patient selection" domain and a high risk of bias in the "Index test" domain. The meta-analysis of the case-control studies demonstrated a sensitivity of 81% and specificity of 82%, whereas the meta-analysis of the cross-sectional studies showed a sensitivity of 80% and specificity of 85%, both with 95% confidence intervals. The certainty of the evidence was rated as "low." CONCLUSION: This systematic review showed that serum anti-Müllerian hormone levels can serve as a diagnostic marker for polycystic ovary syndrome when factors such as age, test standardization, polycystic ovary syndrome phenotypes, and body mass index are considered. Otherwise, anti-Müllerian hormone should be used as an adjuvant to the polycystic ovary syndrome diagnostic criteria established through consensus and/or guidelines. Additionally, serum concentrations reflected the severity of this syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro - UFTM, Abadia, Uberaba-MG, Brazil. Electronic address: mariane.gomes1967@gmail.com.
- Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro - UFTM, Abadia, Uberaba-MG, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Gomes, M. O., Gomes, J. O., Ananias, L. F., Lombardi, L. A., da Silva, F. S., & Espindula, A. P. (2025). Anti-Müllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2025.01.044
Vancouver
Gomes MO, Gomes JO, Ananias LF, Lombardi LA, da Silva FS, Espindula AP. Anti-Müllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis. American Journal of Obstetrics and Gynecology. 2025. doi:10.1016/j.ajog.2025.01.044
BibTeX
@article{Gomes2025,
author = {Gomes, Mariane de Oliveira and Gomes, Juliane de Oliveira and Ananias, Lucas Fernandes and Lombardi, Leonardo Augusto and da Silva, Fernando Seiji and Espindula, Ana Paula},
title = {Anti-Müllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis},
journal = {American Journal of Obstetrics and Gynecology},
year = {2025},
doi = {10.1016/j.ajog.2025.01.044}
}
EUVIMED